D. Hwang

Bispecific anti-mPDGFRβ x cotinine scFv-Cκ-scFv fusion protein and cotinine-duocarmycin can form antibody-drug conjugate-like complexes that exert cytotoxicity against mPDGFRβ expressing cells.

Junho Chung, Soohyun Kim, Hyori Kim, 2019, Methods.

A Hybrid Platform Based on a Bispecific Peptide-Antibody Complex for Targeted Cancer Therapy.

Dong Yun Lee, Junho Chung, S. Jon, 2019, Angewandte Chemie.

Crystal structure of h38C2 K99R mutation

Cameron, M. Cameron, W. Roush, 2019 .

Antibody-Assisted Delivery of a Peptide-Drug Conjugate for Targeted Cancer Therapy.

Soyoung Lee, Junho Chung, S. Jon, 2018, Molecular pharmaceutics.

Site-Specific Antibody–Drug Conjugates in Triple Variable Domain Fab Format

C. Rader, D. Hwang, Dobeen Hwang, 2020, Biomolecules.

Site-Specific Lysine Arylation as an Alternative Bioconjugation Strategy for Chemically Programmed Antibodies and Antibody-Drug Conjugates.

T. Burke, Hajeung Park, C. Rader, 2019, Bioconjugate chemistry.

Sculpting a Uniquely Reactive Cysteine Residue for Site-Specific Antibody Conjugation.

Raktim N. Roy, W. Roush, Hajeung Park, 2022, Bioconjugate chemistry.